Recombinant Human VEGF Co-regulated Chemokine 1/CXCL17 (rHuVCC-1/CXCL17)

Cat No.

RP00690

Product Specifications

Product Type

Recombinant protein

Applications

Bioactivity, Endotoxin

Source

E. coli.

UniProt No.Q6UXB2
Purity

> 96 % by SDS-PAGE and HPLC analyses.

Bioactivity

Fully biologically active when compared to standard. The ED50 as determined by its ability to induce VEGF expression using Mouse endothelial cells is less than 5.0 μg/ml, corresponding to a specific activity of > 200 IU/mg.

Endotoxin

Less than 0.1 EU/μg of rHuVCC-1/CXCL17 as determined by LAL method.

Molecular Weight

Approximately 11.5 kDa, a single non-glycosylated polypeptide chain containing 98 amino acids.

Formulation

Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4, with 3 % Trehalose.

Alternative Names

VCC-1/CXCL17, Human

Storage

-20C

Reconstitution

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.

Research Area

Immunology